Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001683168-24-000708)

Filing Details

Accession Number:: 0001683168-24-000708
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-02-06 10:28:10
Reporting Period:: 2024-02-01

Accepted Time:: 2024-02-06 10:28:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1729427	Cns Pharmaceuticals Inc.	CNSP	Pharmaceutical Preparations (2834)	822318545

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1793252	Jerzy Gumulka	C/O Cns Pharmaceuticals, Inc. 100 West Loop South, Suite 900 Houston TX 77027		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-02-01	33,333	$0.30	43,006	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Warrant to purchase common stock	Acquisiton	2024-02-01	33,333	$0.00	33,333	$0.30
Common Stock	Series B Warrant to purchase common stock	Acquisiton	2024-02-01	33,333	$0.00	33,333	$0.30

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
78,761	2024-02-01	2029-02-01	No	4	A	Direct
112,094	2024-02-01	2025-10-01	No	4	A	Direct

Footnotes

The common stock, Series A warrants and Series B warrants were acquired by the reporting person in a public offering conducted by the Company that was closed on February 1, 2024.